- Work +1 215 994 4000
- Fax +1 215 994 2222
United States: Antitrust
Civil litigation/class actions
Dechert LLP has a prominent standing in contentious merger matters. In a recent example, Paul Denis, deputy chair of the firm’s global litigation practice, and Mike Cowie led advice to General Electric in contesting the DOJ’s challenge to its proposed $3.3bn sale of GE Appliances to Sweden’s Electrolux; the transaction was ultimately aborted. On the class actions side, Philadelphia-based Christine Levin successfully obtained, for key client R.W. Sauder, the dismissal of a motion to certify a class by a putative class of indirect purchasers alleging that producers of eggs and egg products conspired to reduce supply. Other clients include American Airlines and Dow. Paul Friedman, who like Denis and Cowie is located in Washington DC, and New York-based Michael Weiner are also recommended. Steven Bizar, an experienced antitrust and trade regulation litigator, joined from Buchanan Ingersoll & Rooney in February 2016.
Dechert LLP’s US antitrust practice, which operates across 13 offices, continues to be active on large and complex deals, among them 15 transactions worth more than $1bn. ‘Very good lawyer’ Paul Denis took the lead in securing FTC clearance for the $9.4bn merger of Albertsons and Safeway. In another highlight, James Fishkin was part of the team advising Dollar Tree on its $8.5bn acquisition of Family Dollar, two of the largest discount merchandise store chains in the US. The group also represented Fibertech in its sale to Lightower, which turned two leading independent providers of fiber optic cables in the Northeast into a Northeast and Mid-Atlantic powerhouse. Philadelphia-based George Gordon and Michael Weiner in New York head the department. Craig Falls was promoted to partner, and trial lawyer Steven Bizar joined the firm’s Philadelphia office after leaving Buchanan Ingersoll & Rooney. Since publication,
Ethan Litwinjoined from Hughes Hubbard & Reed LLP.
Paul Denis - Dechert LLP
United States: Dispute resolution
General commercial disputes
Dechert LLP has significant geographical reach with resources in cities across the US and internationally. The highly regarded David Bernick was part of a cross-office team which represented AbbVie in product liability litigation that includes an MDL and individual actions in four states. The class action practice remains active; San Francisco-based Joseph Escher is representing Golden Living in two class action cases in California and Arkansas. Other major cases that continue to keep the department busy include its representation of NML Capital in ongoing litigation against the Republic of Argentina to recover debts; Robert Cohen, Steven Engel and Dennis Hranitzky have key roles. Andrew Levander and Los Angeles-based William Oxley are also recommended. Above-named partners are based in New York unless otherwise stated.
Dechert LLP made great strides toward becoming an international arbitration powerhouse when Arif Ali and Alexandre de Gramont left Weil, Gotshal & Manges LLP to join the Washington DC office in August 2015. Ali, who co-chairs the group, represents parties around the globe in commercial and investment treaty arbitrations in a wide variety of industries. In one work highlight, he and de Gramont represented Hungary against claims by EDF related to the government’s termination of power purchase agreements that were allegedly required due to the state’s accession to the EU. Ali represents the Czech Republic in UNCITRAL arbitration proceedings against a group of investors regarding a dispute that arose from the privatization of a state-owned enterprise. Other key clients include Ecuador, Bolivia, MOL Hungarian Oil and Gas and major corporations in the software and pharmaceutical industries.
Dechert LLP’s US-based international litigation team is ‘super sharp, practical and thorough’, and represents individuals, corporations, financial institutions and investors across the globe. The US team works closely with the firm’s offices in London, Paris, Moscow, Hong Kong and Singapore. Dennis Hranitzky and Robert Cohen, both based in New York, have decades of experience handling complex international commercial disputes and enforcement proceedings against foreign governments and government agencies. The two recently teamed up with Andrew Hearn in the London office and Xavier Nyssen in the Paris office to represent NML Capital in a $3bn dispute regarding defaulted sovereign bonds issued by Argentina. Litigation and parallel enforcement proceedings are ongoing in the US, UK, France, Switzerland, Belgium, Luxembourg and Ghana. In another highlight, Allan Brilliant and Hranitzky were lead counsel to an ad hoc group of noteholders in connection with cross-border restrictions placed on $1.6bn in defaulted senior notes issued by Mexico’s largest glass manufacturer. Washington DC-based Jeremy Zucker focuses on regulations and investigations, and is well versed in areas such as the Foreign Corrupt Practices Act (FCPA) and the anti-money laundering provisions of the Patriot Act.
Dennis Hranitzky - Dechert LLP
Robert Cohen - Dechert LLP
Product liability, mass tort and class action: consumer products (including tobacco)
Product liability, mass tort and class action: consumer products (including tobacco) - ranked: tier 3
Dechert LLP’s product liability and mass torts litigation department has substantial trial and appellate experience, extending to class actions, mass torts and regulatory matters. Chicago-based Erik Snapp is currently defending Pfizer as trial counsel in a statewide consumer fraud class action in the Southern District of California alleging false advertising of prescription drugs Premarin, Prempro and Premphase. Other clients include Johnson & Johnson, Philip Morris and Union Carbide. Austin-based Amy Rudd and Chicago-based Nathan Hoffman are also recommended. Donald Le Gower is now in-house counsel at Bristol-Myers Squibb.
Product liability, mass tort and class action: pharmaceuticals and medical devices - defense
Product liability, mass tort and class action: pharmaceuticals and medical devices - defense - ranked: tier 2
Headed by Philadelphia-based Ben Barnett, Dechert LLP’s team continues to represent high-profile clients at trial and appellate levels. New York-based David Bernick is serving as lead trial counsel to AbbVie in national product liability litigation concerning the client’s testosterone replacement therapy drug AndroGel, which includes an MDL involving over 2,400 claimants alleging personal injury caused by the drug. Chicago-based David Kistenbroker is currently representing Endocyte and its CEO in claims alleging the defendants made false and misleading statements regarding the company’s experimental drug, Vynfinit. Donald Le Gower is now in-house counsel at Bristol-Myers Squibb.
Product liability, mass tort and class action: toxic tort - defense
At Dechert LLP, Philadelphia-based Ben Barnett’s department has a strong track record in handling high-profile litigation on the trial and appellate level. Led by Nathan Hoffman, the firm continues to defend Pfizer in ‘apparent manufacturer’ asbestos litigation arising from the operations of its former subsidiary Quigley before a number of Pennsylvania state courts. The team includes Los Angeles-based William Oxley, who is ‘a very good trial lawyer’, and Philadelphia-based Meghan Kelly, who was promoted to partner. Donald Le Gower is now in-house counsel at Bristol-Myers Squibb.
Securities litigation - defense
Dechert LLP has ‘a vigorous and spirited defense team’ that is ‘very strong, especially in representing directors and officers’. The firm’s outstanding partners include global litigation head Matthew Larrabee (‘tough and aggressive’, ‘very impressive in oral advocacy and in all presentations’) and Andrew Levander (‘a superstar, very bright, measured and strategic’) in New York, and David Kistenbroker in Chicago. Larrabee and David Kotler are acting for Calamos in a $100m lawsuit brought by two shareholders in one of the company’s mutual funds. Levander is involved in a $200m matter for Universal American. Kistenbroker is representing Delcath Systems in a shareholder class action alleging the company made false and misleading statements about its application for new liver cancer drug Melblez. Clients also praise Michael Doluisio in Philadelphia as ‘very straightforward and good on the details’ and New York-based Hector Gonzalez. The firm is one of the leaders in the mutual fund area and in ’40 Act matters.
Andrew Levander - Dechert LLP
David Kistenbroker - Dechert LLP
White-collar criminal defense
Dechert LLP has a ‘terrific’ white-collar practice headed by New York-based ‘superstar’ Andrew Levander and the Washington DC-based Catherine Botticelli. AIG, Merrill Lynch, UBS and Microsoft are among the firm’s clients. Recent highlights include representing Takata and its affiliates in litigation and investigations conducted by various authorities into its airbags. The firm served as counsel to First Eagle Investment Management during a nationwide SEC investigation into mutual funds. New York’s Jonathan Streeter is leading the firm’s representation of a Chinese national accused of insider trading. Additional areas of expertise for the firm include FCPA investigations and other anti-bribery work, and it has also handled matters involving allegations of forex-related misconduct. Michael Barta, who is based in Washington DC, is also recommended. Since publication, David Kelley has joined from Cahill Gordon & Reindel LLP.
Andrew Levander - Dechert LLP
United States: Finance
Capital markets: debt offerings
Dechert LLP’s capital markets practice is ‘outstanding in every way’, advising issuers from a range of industries, and also underwriters, on the full spectrum of debt work. Led by New York-based David Rosenthal and Boston-based Thomas Friedmann, the team has practitioners operating across its US and international network. ‘I would never use anyone else’, says a client who compliments in particular the ‘response times, specific practice knowledge and value’. The firm has a strong showing among life sciences, private equity and BDC clients. Recent highlights include advising FS Investment Corporation, a BDC, on its public offering of $325m of unsecured notes and acting for pharma company Egalet on its offering of $60m of senior convertible notes. Philadelphia-based Eric Siegel is hailed for his ‘consistent, measured and thoughtful advice’.
Capital markets: equity offerings
Dechert LLP handles a broad mix of issuer and underwriter-side equity deals, with notable experience in the life sciences sector and in permanent capital vehicles. The firm has also advised on numerous cross-border matters, acting on deals across Europe, Asia and Latin America. David Rosenthal is advising Citigroup and Jefferies on the $86m cross-border IPO of American depositary shares in Advanced Accelerator Applications, a French radiopharmaceutical company; and Philadelphia-based James Lebovitz is assisting FS Investment Corporation IV with its continuous public offering of shares totaling $2.7bn. Boston-based Thomas Friedmann is also a leading figure, having recently advised Eagle Point Credit Company on its $103m IPO of common stock. Additional key clients include Goldman Sachs, Edge Therapeutics and Golub Capital.
Capital markets: global offerings
Dechert LLP’s ‘excellent in-depth knowledge of the global capital markets’ is illustrated by its diverse client base which includes Deutsche Bank, Citigroup and Zealand Pharma. While the ‘well-known and respected attorney’ Howard Kleinman, who ‘stands out from the crowd for his capital market expertise’, concentrates on Latin America-based matters, the rest of the team regularly acts for issuers and underwriters in Asia, the Middle East and Europe, with a particular focus on matters related to life sciences. In New York, David Rosenthal, who jointly heads the practice with Boston-based Thomas Friedmann, was recently retained by an underwriting syndicate, led by JMP Securities as sole book-running manager, in a $50m cross-border IPO of ordinary shares listed on NASDAQ by Israel-based Mapi Pharma. In Philadelphia, William Lawlor and Ian Hartman assisted Crown Holdings with a €600m offering of senior unsecured notes due 2025.
Capital markets: high-yield debt offerings
Dechert LLP earns praise for its ‘excellent service and speedy response times’ and, according to one client, for ‘getting up-to-speed with our business quickly’. It is noted for its work with private equity firms and emerging companies, and has a particularly strong profile within the life sciences and pharmaceuticals sector. In the high-yield space, a team led by New York-based David Rosenthal recently advised Egalet on a $60m Rule 144A/Regulation S private placement. Rosenthal chairs the practice alongside Boston-based Thomas Friedmann; other notable names are Howard Kleinman and Richard Goldberg in New York and William Lawlor and Ian Hartman in Philadelphia. Goldberg is commended for his ‘excellent responsiveness and commanding subject-matter knowledge’.
Dechert LLP has a strong pedigree for acting for direct lending financiers, particularly in the middle market. It is adept at handling restructurings and Scott Zimmerman advised a second lien steering group, as the second lien agent, on restructuring Edmentum’s equity and debt capital structure. The team is equally skilled advising banking clients, and Philadelphia-based Sarah Gelb led a team serving as drafting counsel to the lead lenders on the financing of CPP Investment Board’s acquisition of the Antares business platform. Jeffrey Katz is a key name on the borrower side, where the firm's clients include Bregal Partners and B&G Foods. Lending specialist Jay Alicandri is also recommended.
Financial services: regulatory
Led out of Washington DC by ‘learned statesman’ Thomas Vartanian, Dechert LLP’s ‘thorough and client-friendly’ four-partner team provides compliance, enforcement and M&A expertise to domestic and international banks, insurance companies and industry associations. Leveraging the firm’s excellent ties with the asset management community, the team is active advising private equity and hedge funds as they come to terms with the various restrictions placed upon them by the Volcker rule. As well as standalone compliance and advisory work, Vartanian also provides the regulatory overlay to transactions in the industry including in relation to Wells Fargo’s $9bn acquisition of commercial real estate loans from GE Capital Real Estate. The ‘insightful’ David Ansell recently advised Certares and an investor group on a joint venture with American Express to engage in the global corporate travel business.
Restructuring (including bankruptcy): corporate
Dechert LLP’s ‘cost-effective, streamlined’ team is a natural choice for investment funds, given the firm’s exemplary strength in that arena, with clients including the likes of Stonehill Capital Management, UBS Securities and Solus Alternative Asset Management. It has landed prized creditor roles in some of the largest ongoing proceedings, acting for major noteholders in the restructurings of OAS and Trump Entertainment Resorts and for first lien holders of $1.1bn of the $4.1bn of debt in Momentive Performance Materials. Playing to its strengths in litigation, the firm - most recently through Eric Brunstad - has filed numerous amicus briefs on points of bankruptcy law, and has won notable judgments for client NML Capital in the Supreme Court in its consideration of the Republic of Argentina’s sovereign bond default. Its ‘super-sharp’ lawyers include team co-heads Michael Sage (‘a voice of reason in difficult negotiations’) and Allan Brilliant, as well as Craig Druehl (‘practical and thorough’), Brunstad and the ‘exceptionally capable’ Shmuel Vasser. All partners named are based in New York, except for Hartford-based Brunstad.
Dechert LLP’s structured finance group is noted for ‘its great finance service, industry resourcefulness and up-to-date knowledge’. The 48-lawyer team has been active advising issuers and underwriters on transactional and regulatory matters relating to ABS, CLOs and CMBS, and helping clients develop structures aimed at complying with the final US risk retention rule (‘Final Rule’), including the innovative C-MOA structure. It has also been at the forefront of advising on SFR securitization. Charlotte-based head of practice John Timperio and Cinthia Williams in Boston headed the advice to Deutsche Bank, Credit Suisse and Citibank, as lenders, on the financing provided for the acquisition of the Antares business platform from GE, by CPP Investment Board. Richard Jones led the group acting for Progress Residential, as issuer, in relation to its SFR program. Also based in New York, Laura Swihart is praised for her expertise in the CMBS arena. The ‘highly responsive’ Malcolm Dorris is known for his work in ABS for underwriter clients. Stewart McQueen is noted for his expertise in securitizations. Freddie Mac, Cerberus and Wells Fargo are among the firm’s other clients. Since publication, CMBS expert Jodi Schwimmer has joined Reed Smith LLP in New York.
United States: Industry focus
Healthcare: life sciences
Singled out for its cross-border capabilities, Dechert LLP’s life sciences team, which is led by Washington DC-based corporate specialist David Schulman and Philadelphia-based George Gordon, handles corporate and IP counseling and transactions, and product liability litigation on behalf of a broad range of life sciences clients. Gordon focuses on antitrust litigation, counseling and government investigations, and regularly represents life science companies in disputes arising from licensing, collaboration, asset purchases and other agreements. Recent work for the team included advising AM-Pharma on the sale of a minority interest in the company to Pfizer and the grant of an exclusive option to Pfizer to acquire the remaining equity. It also advised Celgene International Sàrl, a subsidiary of Celgene Corporation, in its $450m strategic alliance with MedImmune, a subsidiary of AstraZeneca, to develop and commercialize an anti-PD-L1 inhibitor, MEDI4736, for hematologic malignancies. In another highlight, IP litigator Martin Black won a Hatch-Waxman judgment for Endo Pharmaceuticals against seven generics, protecting an estimated $2bn in sales.
United States: Intellectual property
Trademarks: non-contentious (including prosecution, portfolio management and licensing)
Trademarks: non-contentious (including prosecution, portfolio management and licensing) - ranked: tier 2
Dechert LLP’s team handles trademark clearance, registration and enforcement for several longstanding clients in a variety of industries. The ‘very talented’ practice head Glenn Gundersen in Philadelphia has been acting for many well-known Swiss luxury watch brands, including Breitling, Ebel, and TAG Heuer. He has also assisted The Ivy League with the prosecution and enforcement of its brand, including actions against several apparel producers. In addition, the practice has represented Apple in several opposition and cancellation proceedings before the TTAB. Other clients include Zara and Towers Watson.
Glenn Gundersen - Dechert LLP
United States: Investment fund formation and management
Led by George Mazin, Dechert LLP’s team acts for a range of sponsors, from start-up managers to global institutions, on fund formation and structuring, as well as on issues arising from fund management, regulatory compliance and enforcement. The firm’s ability to leverage its global footprint enables it to tackle complex cross-border issues, including global marketing matters and inbound/outbound investments. David Vaughan is experienced in representing fund managers in SEC enforcement cases, and has a background as a former senior private fund policy adviser for the SEC’s investment management division. Elsewhere, its outstanding reputation in the registered funds arena is a draw for alternative asset managers seeking to expand into registered closed-end funds, traditional mutual funds and business development companies. Kevin Scanlan’s move to Kramer Levin Naftalis & Frankel LLP in 2015 was offset by the arrivals of Mark Perlow and Timothy Spangler from K&L Gates and Sidley Austin LLP respectively. Karl Egbert relocated to New York from the Hong Kong office.
Dechert LLP’s sizeable practice leverages its substantial US presence and its extensive global network to advise some of the world’s largest asset management firms on the full spectrum of registered funds, including mutual funds, ETFs, insurance-related products, business development companies and closed-end funds. Its expertise spans corporate and regulatory matters and litigation, as well as ancillary tax, ERISA and executive compensation issues. The practice acts for 22 of the world’s top 25 asset managers, as well as a wide range of registered investment companies (and their boards), broker-dealers and insurance companies; its combined client base represents more than $4 trillion in assets under management. Christopher Harvey jointly heads the practice with Robert Helm. Douglas Dick assisted a registered investment adviser with corporate transactional and regulatory issues associated with its adoption of a family of investment companies. In addition to her experience in closed-end fund IPOs and rights offering, Allison Fumai also advises on ETF product launches and exemptive relief issues. Jeffrey Puretz acts for mutual funds, investment advisers and insurance companies. Richard Horowitz is recommended for his particular knowledge of issues concerning business development companies. Other names to note include Stephen Bier, Anthony Zacharski, John O’Hanlon and Mark Perlow, who recently joined from K&L Gates. Philip Hinkle and Stephen Cohen were promoted to partner.
Robert Helm - Dechert LLP
United States: Labor and employment
Employee benefits and executive compensation
For some, Dechert LLP is ‘a one-stop shop for asset management companies’ with ERISA issues. However, the firm also assists corporates with transaction-related employment issues and executive compensation negotiation. Andrew Oringer, who is based in the New York office, advises a number of investment funds and financial institutions on the compatibility of their products with ERISA. In Philadelphia, David Jones assisted OCI Company with the employee benefits and executive compensation aspects of its sale of OCI Resources to a subsidiary of Ciner Group, which included the transfer of two underfunded defined benefit plans and severance agreements for some of the management staff. Boston-based ‘go-to ERISA practitioner’ Susan Camillo advises Golub Capital on the suitability of collateralized loan obligations as ERISA plan assets. Oringer and Jones share leadership of the practice.
Andrew Oringer - Dechert LLP
United States: M&A/corporate and commercial
M&A: large deals ($1bn+)
Dechert LLP is commended by clients for ‘big-ticket, high-value investments and exits’, and delivers a ‘superb, value-add advice with tremendous acumen and industry knowledge’. The ‘terrific’ team is always ‘available with timely advice whenever needed’. It is well known for its expertise in complex, highly regulated industries, and is notably strong in life sciences and financial services. In 2015, the firm represented MWI Veterinary Supply in its $2.5bn acquisition by AmerisourceBergen Corporation and its wholly-owned subsidiary, Roscoe Acquisition Corp. Continuing to be active on behalf of private equity clients and their portfolio companies, it advised Court Square Capital Partners and Fibertech Holdings on the $1.9bn all-cash merger of Fibertech Holdings Corp and Lightower Fiber Networks. Chair of the global corporate and securities group Mark Thierfelder is ‘a truly superb M&A lawyer who you want in the trenches with you’. Jonathan Kim, Derek Winokur and ‘terrific M&A lawyer’ Christian Matarese are also key names in New York. Philadelphia partner Stephen Leitzell is another senior name and was lead partner on the MWI Veterinary Supply transaction. Philadelphia’s Henry Nassau is chair of the firm’s corporate and securities group, and fellow Philadelphia lawyers William Lawlor, Carmen Romano and Geraldine Sinatra are also names to note.
Private equity buyouts
The ‘superb’ Dechert LLP typically operates in the upper-middle market, and counts the likes of One Equity Partners, Graham Partners and Court Square Capital Partners among its cornerstone clients. Underscoring the firm’s commitment to mid-market clients was the hire of Markus Bolsinger in New York from Kirkland & Ellis LLP; he is dual qualified in Germany and New York. The firm has a substantial fund formation practice and also provides specialist expertise in relation to healthcare, financial services and a range of regulatory areas. Recent work includes representing Bregal Partners in connection with an investment in American Seafoods Group as part of a broader deleveraging recapitalization of the company. The head of the global private equity practice, Mark Thierfelder, is ‘a truly superb M&A lawyer and negotiator who you want in the trenches with you’. ‘All-star’ Derek Winokur has ‘an excellent ability to navigate legal complexities’, and Daniel O’Donnell is also highly regarded. Samantha Koplik and Christian Matarese were promoted to partner. Henry Nassau stepped down as the chair of the corporate and securities group after having been elected CEO of the firm.
United States: Real estate and construction
Praised as ‘better than all the other large firms in the CMBS space’, Dechert LLP’s ‘deep bench’ of attorneys includes head of practice Richard Jones, who divides his time between New York and Philadelphia, and Philadelphia-based David Forti and Jason Rozes. The team continued to be very active in high-value loan origination and securitization mandates for key clients such as Bank of America and Citigroup, and also advised Wells Fargo in relation to its agreement to purchase commercial real estate loans valued at $9bn from GE Capital Real Estate. In New York, Laura Swihart advised Freddie Mac in multiple securitizations totaling more than $120bn, and, in San Francisco, the ‘extremely good’ Kahlil Yearwood, who has ‘developed a strong, young and diverse team’, represented Prudential in multiple mortgage loan origination transactions. The practice has outlets in Charlotte, Boston and Hartford and was further developed in Philadelphia by the promotions to partner of Justin Gdula and Matthew Ginsburg.
United States: Tax
The ‘outstanding’ department at Dechert LLP is ‘very responsive’, advising on complex tax matters pertaining to acquisitions, restructuring, securitization, financing, funds, REITS and transfer pricing. The team advised MacAndrews & Forbes Holdings on its multi-jurisdictional acquisition of Merisant Company. It also acted for Lumara Health in the sale of its Maternal Health business to AMAG Pharmaceuticals and the sale of Women’s Health-Care to Elan Pharma International. Daniel Dunn heads the department from New York, where Richard Hervey and Michael Hirschfeld are also based. In Philadelphia, Edward Lemanowicz and Richard Wild are recommended, and Boston-based Adrienne Baker is experienced advising private and regulated investment companies.
US taxes: non-contentious
Dechert LLP has a national and international tax practice that specializes in acquisitions, divestitures, restructurings, distressed debt and offshore investment funds, particularly in the fields of real estate and life sciences. The chair of the practice, New York-based Daniel Dunn, was the lead lawyer in assisting Wells Fargo in relation to purchasing commercial real estate loans valued at $9bn in the US, UK and Canada from GE Capital Real Estate, as part of an overall transaction worth $23bn. Michael Rufkahr in Washington DC was lead lawyer advising underwriter Credit Suisse on the securitization of mortgage loans acquired from GE Finance.
Further information on Dechert LLP
Please choose from this list to view details of what we say about Dechert LLP in other jurisdictions.
United Arab Emirates
Offices in Dubai
Offices in Brussels
Offices in Beijing
- Corporate and M&A : Foreign firms
- Dispute resolution : Foreign firms
- Intellectual property : Foreign firms
- Banking and finance : Investment funds
- Corporate and M&A : M&A: mid-sized international deals (sub-€500m)
- Private equity : Venture capital
Offices in Paris
- Capital markets : Equity
- Dispute resolution : Commercial litigation
- Dispute resolution : International arbitration
- EU competition and distribution
- Industry focus : Healthcare and life sciences
- Intellectual property : Patents
- Intellectual property : Trade marks, designs and copyrights
- Mergers and acquisitions
- Private equity : Fund formation
- Private equity : Venture and growth capital
Offices in Tbilisi
Offices in Hong Kong
- Dispute resolution : Litigation
- Intellectual property
- Investment funds
- Regulatory: anti-corruption and compliance
Latin America: International firms
Offices in Dublin
Offices in Almaty
- Banking, finance and capital markets
- Corporate, commercial and M&A
- Dispute resolution
- Energy and natural resources
Offices in London
- Corporate and commercial : Corporate tax
- Corporate and commercial : EU and competition: Trade, WTO, anti-dumping and customs
- Corporate and commercial : Equity capital markets
- Corporate and commercial : Financial services
- Corporate and commercial : Flotations: small and mid-cap
- Corporate and commercial : Investment funds
- Corporate and commercial : M&A: mid-market, £50m-£250m
- Corporate and commercial : Partnership
- Corporate and commercial : Private equity: transactions
- Crime, fraud and licensing : Corporate crime (including fraud, bribery and corruption)
- Crime, fraud and licensing : Fraud: white-collar crime
- Dispute resolution : Banking litigation: investment and retail
- Dispute resolution : Commercial litigation
- Dispute resolution : International arbitration
- Dispute resolution : Public international law
- Finance : Corporate restructuring and insolvency
- Finance : Debt capital markets
- Finance : Emerging markets
- Finance : Securitisation
- Human resources : Employment: employees/ unions
- Human resources : Employment: employers and senior executives
- Real estate : Commercial property
- Real estate : Property finance
- Real estate : Property litigation
- TMT (technology, media and telecoms) : Intellectual property
- TMT (technology, media and telecoms) : Pharmaceuticals and biotechnology
Offices in Luxembourg
Offices in Moscow
- Banking and finance : Borrower side
- Banking and finance : Lender or arranger side
- Commercial, corporate and M&A : Moscow
- Dispute resolution : Arbitration and mediation
- Dispute resolution : Litigation
- Energy and natural resources
- Real estate and construction
Offices in Singapore
- Antitrust : Civil litigation/class actions
- Antitrust : Merger control
- Dispute resolution : General commercial disputes
- Dispute resolution : International arbitration
- Dispute resolution : International litigation
- Dispute resolution : Product liability, mass tort and class action: consumer products (including tobacco)
- Dispute resolution : Product liability, mass tort and class action: pharmaceuticals and medical devices - defense
- Dispute resolution : Product liability, mass tort and class action: toxic tort - defense
- Dispute resolution : Securities litigation - defense
- Dispute resolution : White-collar criminal defense
- Finance : Capital markets: debt offerings
- Finance : Capital markets: equity offerings
- Finance : Capital markets: global offerings
- Finance : Capital markets: high-yield debt offerings
- Finance : Commercial lending
- Finance : Financial services: regulatory
- Finance : Restructuring (including bankruptcy): corporate
- Finance : Structured finance
- Industry focus : Healthcare: life sciences
- Intellectual property : Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Investment fund formation and management : Alternative/hedge funds
- Investment fund formation and management : Mutual/registered funds
- Labor and employment : Employee benefits and executive compensation
- M&A/corporate and commercial : M&A: large deals ($1bn+)
- M&A/corporate and commercial : Private equity buyouts
- Real estate and construction : Real estate
- Tax : International tax
- Tax : US taxes: non-contentious